Buoyed by its perceived superiority over PET/CT, early adopters of PET/MRI believe the hybrid modality could be used more often in routine clinical applications within the next five years. However, that predicted growth could hit a speed bump because of PET/MRI’s hefty operational costs and longer scan times [and a lack of reimbursement], according to a paper published online August 11 in the Journal of Nuclear Medicine. {read more here}